Clinical Trial Update: Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH) [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluating the combination of bosentan and inhaled iloprost for idiopathic pulmonary arterial hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Arterial Hypertension
• Pulmonary Arterial Hypertension

Drugs mentioned

• Bosentan (Bosentan)
• Ventavis (iloprost)

Snippet

Sponsor: Hannover Medical School | Conditions: Hypertension | Phase 4 | Status: TERMINATED